The Protective Effect of Vanadium on Cyclophosphamide-Induced Teratogenesis in Mouse Fetus by Torki Al-Rudaini, Amjed & Azadbakht, Mehri
Al-Kufa University Journal for Biology                                     
                                           Print ISSN: 2073-8854                Online ISSN: 2311-6544 
University of Kufa / Faculty of Education for Girls 
Third International Scientific Conference 5-6/12 /2018 
1 
 
The Protective Effect of Vanadium on Cyclophosphamide-Induced 
Teratogenesis in Mouse Fetus 
Amjed Torki Al-Rudaini
*
                                   Mehri Azadbakht
** 
* Department of Biology, College of Science, University of Baghdad, Baghdad Al-Jadiryia, Iraq.  
** Department of Biology, College of Science, University of Razi, Kermanshah, Iran.  
Email of corresponding author: amjed_torki@yahoo.com 
 
Abstract  
Cyclophosphamide(CP) is a chemotherapeutic and immunosuppressive drug used for 
treatment of neoplastic and some auto-immune diseases, but it has several important adverse 
effects and can induce external malformations in the fetus. Different materials can use to 
avoid or prevent its side effects. Trace elements as an antioxidant can prevent oxidative stress 
by binding to free radicals and reduce adverse effects of chemotherapy drugs. vanadium is 
present as an ultratrace element has prophylactic effects on teratogenic effects of CP. The aim 
of our work was to estimate the vanadium effect on CP-induced macroscopic fetal defects in 
mice. In this study pregnant NMRI mice were divided into four groups. control group 
received normal saline, CP group received CP (10 mg/kg on 11
th 
GD), V group received 
vanadium (4mg/kg on 8
th
,10
th
 and 12
th
) and V/CP group CP (10 mg/kg on 11
th 
GD) with 
vanadium (4mg/kg on 8
th
,10
th
 and 12
th
) intraperitoneally. Fetuses were collected on the 19
th
 
GD. Then the weight of fetuses, length of crown-rump, limbs, and tail of fetuses were 
measured. The external teratogenesis were investigated by the stereomicroscope. The results 
revealed that the CP decreased fetal weight, and also reduced the length, limbs, and tail in 
fetuses that received only CP (P≤0.05). In V/CP the reduction in all previous parameters 
significantly increased compared with CP group. CP also caused some types of external 
teratogenesis such as a short neck, short limbs, non-separating fingers and toes from each 
other and malrotated hind limbs, oligodactyly, kinky tail, reduction in the distribution of hair 
follicles on the body surface, and hemorrhage on body surface, while did not notice in V/CP 
group. On the basis of results, vanadium has a significant prophylactic effect on preventing 
teratogenesis that induced via CP. 
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Introduction 
Fetal development abnormalities can be encouraged by drugs, diseases, pollutants, and 
radiation and that can induce oxidative stress and free radicals [1,2]. In experimental animals, 
cyclophosphamide (CP) can induce the oxidative stress [3]. CP is a common 
immunosuppressive and chemotherapy drug used in the treatment of a varied type of 
neoplastic and some auto-immune diseases [4]. CP considered as an active antimitogenic 
agent which interferes with mitosis and prevents the growth of cancer cell [5]. Hepatic 
metabolism of CP take place at mitochondrial level and become active by cytochrome P450 
enzymes [6] and, generates two teratogenic metabolic products acrolein (ACR) and 
phosphoramide mustard (PM) [7, 5, 8]. PM affects DNA, while ACR has the proteins as its 
main target. PM is toxic to the embryo, and acrolein to the yolk sac [9] and responsible for the 
cyclophosphamide anticancer effects, but ACR interacts with the antioxidant immune system 
of the tissues and generates a large number of reactive oxygen species (ROS) that has 
mutagenic properties and can be easily combined with other molecules such as enzymes, 
receptors, ion pumps and caused direct oxidation and inactivating or inhibiting their 
functioning [10], thus causes the apoptosis[11].CP is classified  within class D of drugs, 
therefore known as a pregnancy risk agent. Its use during pregnancy is acceptable only when 
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potential maternal benefits greater than the possible risk such as birth defects [12]. Loss 
weight, stunning size, open eye, polydactyly, syndactyly, synpolydactyly, kinky tail and cleft 
palate are some of the fetal anomalies that induced by CP treatment during embryonic 
development [13,14,15]. 
The use of chemotherapy in cancer patients causes oxidative stress by production of free 
radicals. The use of supplements and vitamins such as vitamins E and A as well as some of 
the trace elements as an antioxidant can prevent oxidative stress by binding to free radicals 
and improve therapeutic methods and reduce its negative effects [16,17]. Metals and its 
compounds have been used for several years to treat diseases such as bismuth, antimony, 
arsenic, iron, titanium, gold, rhodium, gallium, platinum and vanadium, as arsenic, bismuth, 
gold, radium, titanium, gallium, platinum, and vanadium have anticancer activities [18]. 
Vanadium is one of an essential trace element in body of many species that is widely 
distributed on earth. Though, the role of vanadium as a micronutrient in man has yet to be 
established. Man and other species of animals may be received the metal from the atmosphere 
and food [19]. Foods contain low vanadium concentrations (about 1 ng/g), the dietary intake 
of vanadium varies between 10-06 µg /day, the plasma concentration is approximately 20 nM, 
and the total body pool is about 100-200 µg /day [20]. Vanadium can cross the placenta in 
mice and rats [21,22] and store in certain parts of the embryo. Edel and Sabbioni showed the 
storage of vanadium in the liver, intestines, kidneys, and bones take place [22]. Vanadium 
compounds in low concentration did not cause significant incidence of visceral and gross 
malformations in mouse fetuses [23]. Some biological effects of vanadium are an insulin-like 
effect [24,25] and decreased fat and blood pressure [26]. Experiments have shown no 
significant effect when vanadium used at doses lower than 40 mg/kg in adult male and female 
mice on the mating rate when it was taken before mating, but at higher doses, it reduced 
fertility rates. In addition, the administration of vanadium at low doses in pregnancy and 
lactation does not have a direct impact on the development of the embryo and the neonate, 
which proves that vanadium is a concentration-dependent element that can have different 
effects [27]. 
The aim of the current work was to study the effect of vanadium on cyclophosphamide-
induced macroscopic fetal defects in mice. 
Materials & Methods 
Fifty-two NMRI adult female mice, of an average weight of 30±2 gm and an average age 
of 8-10 weeks were purchased from Pasteur Institute of Iran and used in this study. The 
animals were housed individually in plastic cages in noise-free, air-conditioned animal house 
of Biology Department, Science Faculty, Razi University (Kermanshah, Iran). Mice were fed 
ad libitum by standard laboratory pellet (Pars Company's feed, Iran) with temperature 22±2°C 
with a relative humidity of 30-40% maintained at and on a light-dark cycle of 12:12 hours. 
The experiment was conducted according to the norms of the Ethics Committee in Animal 
Experimentation of Razi university and registered under the protocol number 396-1-022. The 
female mice in their proestrous were caged overnight with males (Female: Male = 3:1), after 
which females were examined for evidence a vaginal copulatory plug. Presence of vaginal 
plug on the following morning established start of pregnancy and the day was numbered as 
the day 'zero' of gestation. Pregnant mice were randomly divided into four main experimental 
groups (n=13): control group was received saline for prompting parallel condition (injection 
and handling) to other groups. CP group received CP (Baxter company Oncology GmbH, 
Germany) at the dose (10 mg/ kg, intraperitoneally ip) on the 11
th
 day of gestation (GD). This 
dose was chosen based on a previous dose-response study of Prakash et al., (2007) (12). V 
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group received vanadium (Sigma company, USA) at dose (4 mg/kg, ip) at 8
th
, 10
th 
and 12
th
 
GD, this dose was chosen according to a study of Zhang et al., (1991) (7), and V/CP group 
which received vanadium (4 mg / kg, ip) at 8
th
, 10
th 
and 12
th 
GD plus CP (10 mg / kg, ip) at the 
11
th
 GD. Pregnant mice were weighed and sacrificed on the 19
th
 GD by cervical dislocation. 
Following a large incision in the animal’s abdomen and uterus, fetuses were exposed and 
collected. The length of crown-rump, forelimbs and hind limbs, and tail in each fetus were 
measured by caliper (pied a coulisse) (Mitutoyo, Kanagawa, Japan). Also, the weight of each 
fetus was measured by sensitive balance (GR-120 A & D, Japan). All fetuses examined 
carefully under the stereomicroscope (Olympus IX-71. Japan) coupled with digital camera (D-
D72.Olympus, Japan) for external anomalies.  
 
Statistical analysis 
      All quantitative data derived from our investigation were analyzed by using the SPSS 
version 20 statistical package and compared by one-way analysis of variance (ANOVA). The 
results were expressed as the Stand Error of Mean (SEM). 𝑃 ≤0.05 was considered as 
statistical significance. 
 
Results 
The gross investigation of the fetuses showed a significant decrease in the mean of crown-
rump length of fetuses that belong to CP group in comparison to control, V, and V/CP groups 
(p≤0.05), while in V/CP group the fetal crown-rump length did not show any significant 
difference with control and V groups, but showed a significant increase compared to CP group 
(p≤0.05) (Fig.1, Table1). The mean of fetal body weight in CP group exhibited a significant 
reduction compared with control, V, and V/CP groups (p≤0.05), while it didn’t show any 
significant difference among control, V, and V/CP groups (p≤0.05) (Table 2).  
 Also, the macroscopic examination revealed a significant reduction in the mean of 
forelimbs and hind limbs length in CP group in comparison to control, V, and V/CP groups 
(p≤0.05), which in V/CP group did not show any difference with control and V groups, but 
showed a significant increase compared with CP group (p≤0.05) (Fig.1, Table 1). The mean of 
fetal tail length showed a significant decrease in CP group compared with control, V, and 
V/CP groups (p≤0.05), while it didn’t show any significant difference among control, V, and 
V/CP groups (p≤0.05) (Table 1).  
The macroscopic examination exhibited various external malformations, of which 
important were, short limbs, non-separating fingers and toes from each other, elephantiasis of 
forelimb, malrotated hind limbs, oligodactyly in hind limbs  (Fig. 2,3), short neck, kinky tail, 
reduction in distribution of hair follicles on the body surface, and hemorrhage on body 
surface, while did not observed in control, V and V/CP groups The skin appearance of fetuses 
that undergo to CP during pregnancy period was mucoid, which was not observed in control, 
V, and V/CP groups during current study.                                                                                                                                                                                                                                   
The maternal weight of pregnant mice at the dissecting day (19
th
 GD) in CP group revealed 
a significant reduction in comparison with control, V and V/CP groups (p≤0.05), while in 
V/CP group which showed a significant decrease compared with control and V groups, but it 
showed a significant increase compared to CP groups (p≤0.05) (Table 2). No maternal deaths 
were observed throughout the course of this study, no fetus was absorbed and dead from all 
studying groups also.  In addition, the results showed that some of the pregnant mice of CP 
group had premature accouchement at different times (day 16
th
and 17
th
) of a gestation period, 
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a 
Significant compared with Control.          
b
 Significant compared with CP 
c 
Significant compared with V                     
d 
Significant compared with V / CP 
  Data are expressed as mean ± (SEM). (ANOVA: p≤0.05) 
CP: cyclophosphamide, V: vanadium, V / CP: vanadium / cyclophosphamide  
 
a 
Significant compared with Control.          
b
 Significant compared with CP 
c 
Significant compared with V                     
d 
Significant compared with V / CP 
Data are expressed as mean ± (SEM). (ANOVA: p≤0.05) 
CP: cyclophosphamide, V: vanadium, V / CP: vanadium / cyclophosphamide 
 
all neonates born on the 16
th
 day of gestation died after a few hours. On the other hand, some 
of the female offspring from pregnant mice of CP, V and V/CP groups, left them for maturing, 
at age 60 days mated with other healthy mature male mice, the female mice offspring from V 
and V/CP groups became pregnant normally, but those of CP group did not become pregnant. 
Some of these female mice when mated with mature male offspring from same treated groups, 
showed that the female mice from V and V/CP groups became pregnant normally, but those 
of CP group did not become pregnant. 
Table 1: Mean of crown-rump, forelimbs, hind limbs, and tail in fetuses from pregnant 
mice who exposed to cyclophosphamide on 11
th
 GD and treated with vanadium on 
8
th
,10
th
, and 12
th 
GD 
Table 2: Mean of maternal and fetal weight in pregnant mice and their fetuses who 
exposed to cyclophosphamide on 11
th
 GD and treated with vanadium on 8
th
,10
th
 and 12
th 
GD 
Group Control CP V V/ CP 
Maternal weigh (gr) 
48.326 ± 
0.372
b,d 
39.428 ± 
0.331
a,c,d 
47.983 ± 
0.367
b,d 
45.978 ± 0.302
 
a,b,c
 
Fetal Weight (gr) 
1.37±0.014
b
 
1.02±0.010
a,
c,d
 
1.35±0.015
b
 1.34± 0.012
b
 
  
 
 
 
 
 
 
 
 
Fig 1. Photograph of crown-rump length in fetuses from pregnant mice who exposed  
to cyclophosphamide on 11
th
 GD and treated with vanadium on 8
th
,10
th
 and 12
th
 GD  
Short tail (white arrow) induced by CP. 
Control: received normal saline, CP: cyclophosphamide, V: vanadium, V/CP: vanadium / cyclophosphamide 
Group Control CP V V/CP 
Crown-rump Length 
(mm) 
24.15±0.08
6
b
 
21.10±0.083
a
,c,d
 
24.11±0.088
b
 
23.53±0.085
b
 
Forelimbs Length (mm) 
7.066±0.02
3
b
 
5.64±0.010
a,c,
d
 
6.98± 0.030
b
 6.95±0.021
b
 
Hind limbs Length (mm) 
7.04±0.018
b
 
5.68±0.012
a,c,
d
 
6.93±0.031
b
 6.97±0.024
b
 
Tail Length (mm) 
11.25±0.15
0
b
 
8.78±0.108
 
a,c,d
 
10.88±0.
 
230
b
 
10.81±0.206
b
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Fig 2. Photographs of dorsal and palmar view of forelimbs in fetuses from pregnant mice who 
exposed to cyclophosphamide on 11th GD and treated with vanadium on 8
th
,10
th
 and 12
th 
GD. 
(Scale bar 200 µm).  B showed elephantiasis (large size of limb) induced by CP.  
A) Control Group, B) CP Group, C) V Group, D) V/CP Group. 1: Dorsal View, 2: Palmar 
View. 
Fig 3. Photographs of dorsal and plantar view of hind limbs in fetuses from pregnant mice 
who exposed to cyclophosphamide on 11
th
 GD and treated with vanadium on 8
th
,10
th
 and 12
th
 
GD. (Scale bar 200 µm). B showed oligodactyly induced by CP. 
A) Control Group, B) CP Group, C) V Group, D) V/CP Group. 1: Dorsal View 2: Plantar 
View 
Discussion 
   As there are no data accessible on vanadium on the teratogenicity of CP in fetuses’ 
mouse. In the current study, for the first time, the protective effect of vanadium on the 
teratogenicity of CP in fetuses’ mouse was estimated. In present investigation CP injected at 
dose 10 mg/kg, ip at 11
th 
GD
 
induced a reduction in length of fetus, forelimbs, hind limbs, and 
tail, also it decreased the fetal weight among all fetuses who their mothers received CP only at 
11
th 
GD. While the administration of vanadium at dose 4 mg/kg, ip on 8
th
,10
th
 and 12
th
 GD 
along with 10 mg/kg of CP on 11
th
 GD could improve the reduction in the length of fetus, 
forelimbs, hind limbs and tail, and fetal weight in fetuses that belong to V/CP group.  
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It is well known that CP causes fetal defects in different species of animals including mice, 
rats, hamsters, and rabbits as well as humans [28]. In the current study, the administration of 
CP 10 mg/kg, ip on 11
th 
GD induced a significant growth retardation and morphological 
alterations in mouse fetuses. Gibson and Becker, (1986) reported that the body weight and 
crown-rump length of fetuses from pregnant mice who had been given CP 10 mg/kg, ip at 12
th
 
and 13
th
 GD were reduced. Fetuses that treated with CP at doses 10 and 20 mg/kg on 11
th
 dpc 
had different types of external malformations, of which important were stunting in size, short 
limbs, malrotated limbs, digits defects, kinking of the tail, and hemorrhage on body surface 
[29]. Intraperitoneal injection of a single dose of CP 20 mg/kg to pregnant rats at the 10
th
 GD, 
induced kinky tail, and digital defects [13]. These results agree with our results which showed 
that the intraperitoneal injection of 10 mg/ kg of CP alone to pregnant mice on the 11
th
 day of 
pregnancy, reduced a fetal weight, crown-rump length, movement limbs and tail length. Also, 
it induced digital defects such as oligodactyly and kinking of the tail. This may due to the 
findings of Mitchell et al., (2003) and Alenzi et al., (2010) that reported that the CP is one of 
the most damaging alkylating agents that can cause oxidative stress due to the over-production 
of reactive oxygen species (ROS) [30, 31]. Also, this drug affects the DNA of replicating cells 
and rapidly multiplying cells which result in miscoding, cross-linking and DNA breakage by 
transferring alkyl groups to the guanine compound of the DNA [32] 
Mahabady et al., (2016) showed that the intraperitoneal administration of CP at dose 15 
mg/kg to pregnant rats at 9
th 
day of pregnancy caused significant growth retardation and 
morphological alterations in rat's fetuses, and also led to reduction the fetal weight and crown-
rump length, and limb defects, when they injected CP plus quercetin 75 or 200 mg/kg ip at 9
th 
GD, observed that the quercetin reduced the anomalies that induced via CP [33]. They 
determined fetal anomalies similar with current investigation including reduction in length 
and weight of fetuses, and limb defects. These defects were recovered by administration of 4 
mg/kg, ip of vanadium on 8
th
,10
th
, and 12
th
 GD. 
Najafzadeh and Mahabadi evaluated the effect of Echinacea purpurea on CP-induced 
malformations. They injected 15 mg/kg, ip of CP to rats at 13
th
 GD [34]. They determined 
fetal defects similar with our study including reduction in length and weight of fetuses, and 
limb defects. These abnormalities improved by using 4 mg/kg, ip of vanadium on 8
th
,10
th
, and 
12
th
 GD. 
Prakash et al. [12] revealed that the intraperitoneal administration of CP at doses 10 and 20 
mg/kg into pregnant mice on 11
th 
GD caused a significant reduction in maternal weight gain 
during gestation. Zhao et al., [35] reported that after treatment the pregnant mice with 50 
mg/kg cyclophosphamide, the maternal body weight was decreased compared with the control 
group. These results are in agreement with our results that showed that the intraperitoneal 
injection of a single dose 10mg/kg of CP caused a reduction in maternal weight. The 
reduction of maternal weight increased significantly by using of vanadium at a dose 4 mg/kg, 
ip on 8
th
,10
th
 and 12
th
 GD along with CP at the dose 10 mg/kg, ip at the 11
th 
GD
.
 
 The maternal weight reduction may be due to gastrointestinal mucosa damaging that 
caused by CP in particular in the intestine, therefore food intake becomes difficult as well as 
the organs dwindle and adipose tissue atrophy [36].  
Conclusion 
According to our results in present study use CP at single dose of 10 mg/kg during second 
semester of pregnancy can induce external anomalies in fetuses such stunning size, lose 
weight, reduction in hair follicle distribution, oligodactyly, and kinky tail. CP can reduce the 
maternal weight also, while administration of 4 mg/kg of vanadium along with CP during the 
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second semester of pregnancy could recover adverse effect of CP on the body of the fetus and 
maternal weight. 
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